Lupus Science and Medicine (Jul 2023)

LO-021 Interim safety and efficacy of subcutaneous (s.c.) dose ianalumab (VAY736; anti-BAFF-R mAb) administered monthly over 28 weeks in patients with systemic lupus erythematosus (SLE)

  • Yuko Kaneko,
  • Masato Okada,
  • Stephanie Finzel,
  • Nan Shen,
  • Elena Vishneva,
  • Lingyun Sun,
  • Bernadette Rojkovich,
  • Alberta Hoi,
  • Shin-Seok Lee,
  • Piotr Leszczyński,
  • Lie Dai,
  • Rafal Wojciechowski,
  • Cheng-Chung Wei,
  • Katarzyna Romanowska-Prochnicka,
  • Hiroshi Kaneko,
  • Stanislav Ignatenko,
  • Alexander Gordienko,
  • Josefina Hernandez,
  • Nancy Levin,
  • Pongthorn Narongroeknawin,
  • Hanna Ciferska,
  • Masanari Kodera,
  • Joung Liang Lan,
  • Tunde Tarr,
  • Yi Hsing Chen,
  • Ajchara Koolvisoot,
  • Eugeny Zotkin,
  • Berta Paula magallares,
  • Tirtha Sengupta,
  • Carole Sips,
  • Stephan Oliver

DOI
https://doi.org/10.1136/lupus-2023-KCR.21
Journal volume & issue
Vol. 10, no. Suppl 1

Abstract

Read online

No abstracts available.